Author + information
- Received June 18, 2018
- Revision received August 13, 2018
- Accepted September 7, 2018
- Published online April 1, 2019.
- Luigi P. Badano, MD, PhDa,b,∗ (, )@lpbadano,
- Rebecca Hahn, MDc,
- Hugo Rodríguez-Zanella, MDd,
- Diego Araiza Garaygordobil, MDd,
- Roberto Carlos Ochoa-Jimenez, MDe and
- Denisa Muraru, MD, PhDa,b
- aDepartment of Cardiac, Thoracic, and Vascular Sciences, University of Padua School of Medicine, Padua, Italy
- bIRCCS, Instituto Auxologico Italiano, S. Luca Hospital, University of Milano-Biococca, Milan, Italy
- cDepartment of Cardiology/Structural Heart and Valve Center, Columbia University Medical Center, New York, New York
- dCardiology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
- eInternal Medicine Department, Mount Sinai St. Luke and Mount Sinai West, New York, New York
- ↵∗Address for correspondence:
Dr. Luigi P. Badano, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Via Giustiniani, 2, 35128 Padua, Italy.
Current guidelines recommend transthoracic echocardiography to assess patients with functional tricuspid regurgitation (FTR) because it provides information regarding the presence of structural abnormalities of the tricuspid valve (TV), allows measurement of tricuspid annulus diameter, and evaluates severity of FTR by integrating data obtained from 2D and Doppler echocardiography. Critical components of the noninvasive evaluation include information regarding TV anatomy, tricuspid regurgitation severity, right ventricular size and systolic function, and associated findings such as estimated pulmonary artery pressure. However, most of the parameters included in the current recommendations to assess FTR are derived from the experience and knowledge developed about the mitral valve and have been transferred from the left to the right side of the heart without accounting for differences in anatomy of the tricuspid and mitral apparatus or for differences in hemodynamic environment in which the TV operates compared to its left counterpart.
- 3-dimensional echocardiography
- functional tricuspid regurgitation
Dr. Hahn is a member of the Speakers Bureau for Boston Scientific and Bayliss; is a speaker and consultant for Abbott Vascular, Edwards Lifesciences, Philips Healthcare, and Siemens Healthineers; and is a consultant for 3Mensio, Medtronic, and Navigate. Drs. Badano and Muraru have received grants from and serve on the Speakers Bureaus of GE Vingmed and TomTec Imaging Systems. Dr. Rodríguez Zanella has received a training grant from the National Institute of Cardiology of Mexico and Mexican Society of Cardiology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received June 18, 2018.
- Revision received August 13, 2018.
- Accepted September 7, 2018.
- 2019 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.